News - Midlands
Catapult invests in Biofortuna
Catapult Venture Managers, which has offices in Leicester and Birmingham, has completed its sixth transaction this year with an investment into Liverpool-based molecular diagnostics company, Biofortuna. Catapult, alongside co-investor Enterprise Ventures (EV) - the venture and growth capital fund manager - have taken part in a £1.1m funding package which will be used to launch the company’s first genotyping products and allow it to continue development of its future product pipeline. Legal advice to EV and Catapult Venture Managers was provided by James Trevis and Jon Gill of Eversheds, and to the company by Craig Scott and Richard McKay of Halliwells.